Unknown

Dataset Information

0

Association of Arsenic Methylation Capacity with Developmental Delays and Health Status in Children: A Prospective Case-Control Trial.


ABSTRACT: This case-control study identified the association between the arsenic methylation capacity and developmental delays and explored the association of this capacity with the health status of children. We recruited 120 children with developmental delays and 120 age- and sex-matched children without developmental delays. The health status of the children was assessed using the Pediatric Quality of Life Inventory (PedsQL) and Pediatric Outcomes Data Collection Instrument (PODCI). The arsenic methylation capacity was determined by the percentages of inorganic arsenic (InAs%), monomethylarsonic acid (MMAV%), and dimethylarsinic acid (DMAV%) through liquid chromatography and hydride generation atomic absorption spectrometry. Developmental delays were significantly positively associated with the total urinary arsenic concentration, InAs%, and MMAV%, and was significantly negatively associated with DMAV% in a dose-dependent manner. MMAV% was negatively associated with the health-related quality of life (HRQOL; -1.19 to -1.46, P?

SUBMITTER: Hsueh YM 

PROVIDER: S-EPMC5112508 | biostudies-literature | 2016 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Association of Arsenic Methylation Capacity with Developmental Delays and Health Status in Children: A Prospective Case-Control Trial.

Hsueh Yu-Mei YM   Chen Wei-Jen WJ   Lee Chih-Ying CY   Chien Ssu-Ning SN   Shiue Horng-Sheng HS   Huang Shiau-Rung SR   Lin Ming-I MI   Mu Shu-Chi SC   Hsieh Ru-Lan RL  

Scientific reports 20161117


This case-control study identified the association between the arsenic methylation capacity and developmental delays and explored the association of this capacity with the health status of children. We recruited 120 children with developmental delays and 120 age- and sex-matched children without developmental delays. The health status of the children was assessed using the Pediatric Quality of Life Inventory (PedsQL) and Pediatric Outcomes Data Collection Instrument (PODCI). The arsenic methylat  ...[more]

Similar Datasets

| S-EPMC3701993 | biostudies-literature
| S-EPMC5333623 | biostudies-literature
| S-EPMC4741109 | biostudies-literature
| S-EPMC5465070 | biostudies-literature
| S-EPMC3727341 | biostudies-literature
| S-EPMC4344188 | biostudies-literature
| S-SCDT-EMBOR-2021-54147V1 | biostudies-other
| S-EPMC4979779 | biostudies-literature
| S-EPMC2329798 | biostudies-literature
| S-EPMC9171692 | biostudies-literature